Sarepta Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 601 | 0.0% | 27,912 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 558 | 0.0% | 28,971 | 9/30/2025 |
| 2025 Q2 | 7/15/2025 | 492 | 0.0% | 28,792 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 1,799 | 0.0% | 28,185 | 3/31/2025 |
| 2024 Q4 | 2/19/2025 | 3,783 | 0.0% | 31,110 | 12/31/2024 |
| 2024 Q3 | 11/15/2024 | 4,108 | 0.0% | 32,892 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 5,456 | 0.0% | 34,530 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 4,432 | 0.0% | 34,234 | 3/31/2024 |
| 2023 Q4 | 2/16/2024 | 3,612 | 0.0% | 37,461 | 12/31/2023 |
| 2023 Q3 | 12/19/2023 | 4,866 | 0.0% | 40,145 | 9/30/2023 |
| 2023 Q2 | 12/19/2023 | 5,060 | 0.0% | 44,181 | 6/30/2023 |
| 2023 Q1 | 12/19/2023 | 6,159 | 0.0% | 44,688 | 3/31/2023 |
| 2022 Q4 | 12/19/2023 | 5,590 | 0.0% | 43,136 | 12/31/2022 |
| 2022 Q3 | 11/15/2022 | 4,668 | 0.0% | 42,232 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 3,141 | 0.0% | 41,899 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 3,382 | 0.0% | 43,286 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 4,034 | 0.0% | 44,796 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 4,135 | 0.0% | 44,717 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 3,540 | 0.0% | 45,532 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 2,981 | 0.0% | 40,004 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 6,310 | 0.0% | 37,010 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 4,144 | 0.0% | 29,511 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 4,552 | 0.0% | 28,388 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 2,697 | 0.0% | 27,571 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 3,122 | 0.0% | 24,194 | 12/31/2019 |